NeuroOne Medical Technologies Corporation (NMTC) |
|
1.38 0 (0%)
|
01-27 15:59 |
|
Open: |
1.38 |
Pre. Close: |
1.38 |
|
High:
|
1.43 |
Low:
|
1.3409 |
|
Volume:
|
19,992 |
Market Cap:
|
22(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:46:37 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 1.99  One year: 2.42 |
| Support: |
Support1: 1.1 Support2: 0.91 |
| Resistance: |
Resistance1: 1.7 Resistance2: 2.07 |
| Pivot: |
1.33 |
| Moving Average: |
MA(5): 1.38  MA(20): 1.34
MA(100): 1.53 MA(250): 1.44 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 49.3 %D(3): 50 |
| RSI: |
RSI(14): 47.5 |
| 52-week: |
High: 3.18 Low: 0.5 |
| Average Vol(K): |
3-Month: 296 (K) 10-Days: 48 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ NMTC ] has closed below upper band by 35.8%. Bollinger Bands are 69.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.43 - 1.44 |
1.44 - 1.44 |
|
Low:
|
1.32 - 1.33 |
1.33 - 1.34 |
|
Close:
|
1.37 - 1.38 |
1.38 - 1.39 |
|
Company Description |
|
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota. |
Headline News |
Fri, 27 Jan 2023
All But a Small Percentage of Congressional Districts have QLICI ... - Novogradac
Wed, 18 Jan 2023
West Virginia Legislation Would Create State NMTC Worth 60% of ... - Novogradac
Tue, 10 Jan 2023
NMTCs Help New Facility for Minnesota's Climate by Design Skate ... - Novogradac
Mon, 09 Jan 2023
NAFOA: 5 Things You Need to Know this Week - indianz.com
Fri, 06 Jan 2023
Track Record, Including Exhibit B, are Critical Components to a ... - Novogradac
Wed, 07 Dec 2022
Numerous Priority Issues Have the NMTC Working Group Looking ... - Novogradac
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
16 (M) |
|
% Held by Insiders
|
1.237e+007 (%) |
|
% Held by Institutions
|
16.3 (%) |
|
Shares Short
|
26 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-9.91e+006 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-473.2 |
|
Return on Assets (ttm)
|
-60.4 |
|
Return on Equity (ttm)
|
-123.8 |
|
Qtrly Rev. Growth
|
3 |
|
Gross Profit (p.s.)
|
1004.17 |
|
Sales Per Share
|
3.16418e+006 |
|
EBITDA (p.s.)
|
-4.55224e+006 |
|
Qtrly Earnings Growth
|
-0.9 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-8 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
1.56 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
494680 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
